Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
4,612
datasets available to search
ShareScore release 0.9.0
Dataset results
4,612 results for “Labels”
A Multicenter, Randomized, Open-labeled, Cross-over, Active-controlled, Phase IV Clinical Trial to Evaluate the Preference of Formulation and the Efficacy and Safety of Renamezin and Kremezin in Pre-d
ClinicalTrials.gov study NCT02681952. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An Open Label, Single-arm, Phase 2 Study of Neoadjuvant Nivolumab and Nab-paclitaxel Before Radical Cystectomy for Patients With Muscle-invasive Bladder Cancer (NURE-Combo)
ClinicalTrials.gov study NCT04876313. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Multi-centre, Open Labelled, Multiple Dosing Trial Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC 0172-2021 Administered Subcutaneously to Healthy Male Subjects and Haemophilia S
ClinicalTrials.gov study NCT01631942. IPD Sharing: Not stated. Countries: 5. Publications: 0.
An Open-label Study Assessing Safety, Immunogenicity and Dose Response of IC84
ClinicalTrials.gov study NCT01296386. IPD Sharing: Not stated. Countries: 2. Publications: 1.
An Open-Label Study to Evaluate the Efficacy and Tolerability of Xanomeline/Trospium In First Episode/Early Phase Schizophrenia Patients
ClinicalTrials.gov study NCT06923891. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Ocrelizumab VErsus Rituximab Off-Label at the Onset of Relapsing MS Disease
ClinicalTrials.gov study NCT04578639. IPD Sharing: NO. Countries: 2. Publications: 0.
Open Label Pharmacokinetic-Pharmacogenetic Study on Polymorphisms in the Organic Cation Transporter OCT1
ClinicalTrials.gov study NCT02054299. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An Exploratory, Open Label, Multi-Center, Non-Randomized Study of [F-18]VM4-037
ClinicalTrials.gov study NCT00884520. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Single Arm, Open Label Trial With Iptacopan Treatment for 24 Weeks, in Patients on Stable Regimen of Anti-C5 Who Switch to Iptacopan.
ClinicalTrials.gov study NCT05630001. IPD Sharing: YES. Countries: 8. Publications: 0.
Open-label Pilot Evaluating Renal Lesions w/ Contrast-enhaced US in Patients w/ Renal Cancer
ClinicalTrials.gov study NCT01751529. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Multicenter Open-label Phase II Trial to Evaluate Nivolumab and Ipilimumab for 2nd Line Therapy in Elderly Patients With Advanced Esophageal Squamous Cell Cancer
ClinicalTrials.gov study NCT03416244. IPD Sharing: NO. Countries: 1. Publications: 3.
Phase 3, Open-label Clinical Trial of EB-101 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)
ClinicalTrials.gov study NCT04227106. IPD Sharing: NO. Countries: 1. Publications: 1.
A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)
ClinicalTrials.gov study NCT00600496. IPD Sharing: YES. Countries: 1. Publications: 3.
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
ClinicalTrials.gov study NCT00573794. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Open-label Study to Evaluate the Effect of MBP-80 on Bone Remodelling
ClinicalTrials.gov study NCT01501344. IPD Sharing: Not stated. Countries: 1. Publications: 22.
Toripalimab ± Sequential Intravesical Gemcitabine-Mitomycin C for BCG-Unresponsive/-Intolerant High-Risk NMIBC: Open-Label Randomized Phase 2 Study
ClinicalTrials.gov study NCT07189793. IPD Sharing: UNDECIDED. Countries: 1. Publications: 6.
A Therapeutic Open Label Study of Tocilizumab in the Treatment of Pulmonary Arterial Hypertension
ClinicalTrials.gov study NCT02676947. IPD Sharing: NO. Countries: 1. Publications: 1.
An Open Label Positron Emission Tomography Study in Healthy Male Subjects to Investigate Brain DAT and SERT Occupancy,Pharmacokinetics and Safety of Single Oral Doses of GSK1360707, Using 11C- PE2I an
ClinicalTrials.gov study NCT01153802. IPD Sharing: YES. Countries: 1. Publications: 1.
Rotational Thromboelastometry (ROTEM™) Guided Transfusion for Elective Procedures in Patients With Cirrhosis (REduCe): An Open Label Randomized Controlled Trial.
ClinicalTrials.gov study NCT05698134. IPD Sharing: NO. Countries: 1. Publications: 1.
Open-label Study of the Effects of Montelukast in Patients With Chronic Cough
ClinicalTrials.gov study NCT01754220. IPD Sharing: Not stated. Countries: 1. Publications: 3.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.